Me (ME) released a new report on the genetics of homocysteine levels for 23andMe+ Premium members, as well as a blood test for next steps ...

A paper published in the New England Journal of Medicine calls for regulations to protect customers' personal and genetic ...

Me Holding Co. (NASDAQ: ME) shares -were mostly unchanged Friday. The company, a leading human genetics company with a mission to help people access, understand, and benefit from the human genome, ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

23andMe was co-founded in 2006 by Anne Wojcicki. With her ex-husband, Google co-founder Sergey Brin, and her sister Susan, the former CEO of YouTube, Wojcicki quickly became a Silicon Valley power ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and ...

SAN FRANCISCO, March 21, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company with a mission to help ...